| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9782a7590a0f931a405d8673a70ebb09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53d525784d8dfc628a0e714877d5e5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81faa230a0f4345ed946923abd28c5d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca733da0ae6ac4d84ea783879b8deda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd3765a557df528f52bce9427d424f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e11b1d756cd89fc7321beae6753a7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d38eb262e63ab827716830ffbff4b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e557c3eea13bc6b9456db0e199adf15a |
| publicationDate |
2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021043986-A1 |
| titleOfInvention |
Methods and means for diagnosing lung cancer |
| abstract |
The present invention relates to diagnosing lung tumours. The invention provides methods which are suitable for diagnosing lung tumours on the basis of samples taken either during surgery or from lung biopsies (here e.g. by means of DNA micro arrays) and on the basis of liquid biopsies. In the case of liquid biopsies, cell-free DNA (cfDNA) is used. Both particularly suitable analysis methods and particularly suitable sets of methylation markers are described. The subject matter of the invention also relates to means which are suitable for diagnosing lung cancer by testing the methylation of a set of methylation markers, e.g. in cell-free DNA (cfDNA) from liquid biopsy samples from patients, wherein the means comprises oligonucleotides which are able to hybridise with DNA that comprises the methylation markers, and relates to the use of these methods and means for diagnosing, i.e. for example determining, subtyping and prognostic characterisation of lung tumours. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113106151-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115274124-A |
| priorityDate |
2019-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |